Ventricular Tachycardia in Patients with Hypertrophy and Heart Failure

Cardiac Electrophysiology: Fourth Edition

Volumn , Issue , 2004, Pages 608-617

  Vos, Marc A ^a   Crijns, Harry J ^b,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904137799     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-7216-0323-8/50068-3     Document Type: Chapter

References (59)

1. Stevenson WG, Stevenson LW Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol 2001, 12:112-114.
2. Beuckelmann DJ, Nabauer M, Erdmann E Alterations of K currents in isolated human ventricular myocytes from patients with heart failure. Circ Res 1993, 73:379-385.
3. Kaab S, Dixon J, Duc J, et al. Molecular basis of transient outward potassium current downregulation in human heart failure: A decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 1998, 98:1383-1393.
4. Jiang MT, Lokuta AJ, Farell EF, et al. Abnormal calcium release, but normal ryanodine receptors, in canine and human heart failure. Circ Res 2002, 91:1015-1022.
5. Ogletree-Hughes ML, Stull LB, Sweet WE, et al. Mechanical unloading restores β-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 2001, 104:881-886.
6. Hasenfuss G, Pieske B Calcium cycling in congestive heart failure. J Mol Cell Cardiol 2002, 34:951-969.
7. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell 2000, 101:365-376.
8. Tsuji Y, Opthof T, Kamiya K, et al. Pacing induced heart failure causes a reduction of delayed rectifier potassium currents along with a decrease in calcium and transient outward currents in rabbit ventricle. Cardiovasc Res 2000, 48:300-309.
9. Pogwizd SM, Schlotthauer K, Li L, et al. Arrhythmogenesis and contractile dysfunction in heart failure. Circ Res 2001, 88:1159-1169.
10. Li GR, Lau CP, Ducharme A, et al. Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol 2002, 283:H1031-H1041.
11. Lacroix D, Gluais P, Marquie C, et al. Repolarization abnormalities and their arrhythmogenic consequences in porcine tachycardia induced cardiomyopathy. Cardiovasc Res 2002, 54:42-50.
12. Sipido KR, Volders PG, Vos MA, Verdonck F Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: A new target for therapy?. Cardiovasc Res 2002, 53:782-805.
13. Tsuji Y, Opthof T, Yasui K, et al. Ionic mechanisms of acquired QT prolongation and Torsade de pointes in rabbits with chronic complete atrioventricular block. Circulation 2002, 106:2012-2018.
14. Jiang M, Cabo C, Yao JA, et al. Delayed rectifier K currents have reduced amplitudes and altered kinetics in myocytes from infarcted canine ventricles. Cardiovasc Res 2000, 48:34-43.
15. Rials SJ, Xu X, Wu Y, et al. Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits. Am J Physiol 1998, H1216-H1224.
16. de Groot SH, Schoenmakers M, Molenschot MM, et al. Contractile adaptations preserving cardiac output predispose the hypertrophied canine heart for DAD-dependent ventricular arrhythmias. Circulation 2000, 102:2145-2151.
17. Li D, Fareh S, Leung TK, Nattel S Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999, 100:87-95.
18. Antzelevitch C Drug-induced channelopathies. Cardiac Electrophysiology: From Cell to Bedside 2004, WB Saunders, Philadelphia, PA. D. Zipes, J. Jalife (Eds.).
19. Marx SO, Kurokawa J, Reiken S, et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295:496-499.
20. Schram G, Pourrier M, Melnyk P, Nattel S Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res 2002, 90:939-950.
21. Kanno S, Saffitz JE The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 2001, 10:169-177.
22. + current in dogs with chronic complete atrioventricular block and acquired Torsade de Pointes. Circulation 1999, 100:2455-2461.
23. Hsieh MH, Chen YJ, Lee SH, et al. Proarrhythmic effects of ibutilide in a canine model of pacing induced cardiomyopathy. Pacing Clin Electrophysiol 2000, 23:149-156.
24. Volders PG, Vos MA, Szabo B, et al. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: Time to revise current concepts. Cardiovasc Res 2000, 46:376-392.
25. Vos MA, van Opstal JM, Leunissen HD, Verduyn SC Electrophysiological parameters and predisposing factors in the generation of drug induced Torsade de Pointes arrhythmias. Pharmacol Ther 2001, 92:109-122.
26. Pogwizd SM, McKenzie JP, Cain ME Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 1998, 98:2404-2414.
27. Huang B, Qin D, El Sherif N Early downregulation of K-channel genes and currents in the postinfarction heart. J Cardiovasc Electrophysiol 2000, 11:1252-1261.
28. Zobel C, Kassiri Z, Nguyen TT, et al. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes. Circulation 2002, 106:2385-2391.
29. Hill JA, Karimi M, Kutschke W, et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000, 101:2863-2869.
30. Peschar M, Vernooy K, Vanagt W, et al. Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles. Cardiovasc Res 2003, 58:510-517.
31. Haq S, Choukroun G, Lim H, et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 2001, 103:670-677.
32. Burkhoff D, Holmes JW, Madigan J, et al. Left ventricular assist device-induced reverse ventricular remodeling. Prog Cardiovasc Dis 2000, 43:19-26.
33. Harding JD, Piacentino V, Gaughan JP, et al. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 2001, 104:1241-1247.
34. Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002, 105:438-445.
35. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002, 40:111-118.
36. Pratt CM, Greenway PS, Schoenfeld MH, et al. Exploration of the precision of classifying sudden cardiac death. Circulation 1996, 93:519-524.
37. Epstein AE, Carlson MD, Fogoros RN, et al. Classification of death in antiarrhythmia trials. J Am Coll Cardiol 1996, 27:433-442.
38. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883. Multicenter Automatic Defibrillator Implantation Trial II Investigators.
39. Berger RD, Kasper EK, Baughman KL, et al. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997, 96:1557-1565.
40. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996, 334:1349-1355.
41. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) A randomised trial. Lancet 1999, 353:9-13.
42. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353:2001-2007.
43. Packer M, Coats AJ, Fowler MB, et al. Carvedilol Prospective Randomized Cumulative Survival Study Group: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651-1658.
44. Cohn JN, Tognoni G A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667-1675. Valsartan Heart Failure Trial Investigators.
45. Dagenais GR, Yusuf S, Bourassa MG, et al. Effects of ramipril on coronary events in high-risk persons: Results of the Heart Outcomes Prevention Evaluation Study. Circulation 2001, 104:522-526. HOPE Investigators.
46. Hart RG, Halperin JL Atrial fibrillation and thromboembolism: A decade of progress in stroke prevention. Ann Intern Med 1999, 131:688-695.
47. Garg RK, Gheorghiade M, Jafri SM Antiplatelet and anticoagulant therapy in the prevention of thrombo-emboli in chronic heart failure. Prog Cardiovasc Dis 1998, 42:225-236.
48. Steinbeck G, Andresen D, Bach P, et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med 1992, 327:987-992.
49. Connolly SJ Evidence based analysis of amiodarone efficacy and safety. Circulation 1999, 100:2025-2034.
50. Pedersen OD, Bagger H, Keller N, et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 2001, 104:292-296.
51. Domanski MJ, Sakseena S, Epstein AE, et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias: AVID Investigators Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 1999, 34:1090-1095.
52. Sheldon R, Connolly S, Krahn A, et al. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian Implantable Defibrillator Study. Circulation 2000, 101:1660-1664.
53. Kuck KH, Cappato R, Siebels J, Ruppel R Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000, 102:748-754.
54. Moss A, Hall W, Cannom D, et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335:1933-1940.
55. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999, 341:1882-1890.
56. Milner PG, Dimarco JP, Lerman BB Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 1998, 11:562-568.
57. Bänsch D, Antz M, Boscor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002, 105:1453-1458.
58. Strickberger SA, Man KC, Daoud EG, et al. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator. Circulation 1997, 96:1525-1531.
59. Rothman S, Hsia H, Cossu S, et al. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: Long-term success and the significance of inducible nonclinical arrhythmias. Circulation 1997, 96:3499-3508.